Igner

Igner 300/12.5mg Tablet

Irbesartan

Winlet Pharmaceuticals (Pvt) Ltd.

Drug Identity

Active Ingredient
Irbesartan
Drug Class
Angiotensin-Ii Antagonists, Combinations
0

How to Take It

Dosage information not available for this product.

Safety Alerts

Severe renal or hepatic impairment
refractory hyperkalaemia, hypercalcaemia
biliary cirrhosis or cholestasis

Important Warnings

Correct volume/salt depletion before starting ther-apy, anaesthesia, renal impairment
monitor serum potassium and creatinine, severe renal impairment, haemodialysis
carefully titrate dose and monitor BP thoroughly, renal artery stenosis, aortic or mitral stenosis, kidney transplant, obstructive hypertrophic cardiomyopathy, severe congestive heart failure, mild to moderate hepatic impairment, primary hyperaldosteronism, primary aldosteronism, hypertensive patients with type 2 diabetes & renal disease, hyperkalaemia
May impair ability to drive or operate machinery

Side Effects

Hyperkalaemiaangioedemasymptomatic hypotension including dizziness particularly in patients with intravascular volume depletione.g. those taking high-dose diureticsarthralgiarhinitisflatulencehypertriglyceridaemiamusculoskeletal traumanausea/vomitingabnormal urination.

Drug Interactions

Diuretics & other antihypertensive agents
K supplements and K-sparing diuretics
lithium
hydrochlorothiazide may interact with alcohol
barbiturates
narcotics
antidiabetics
cholestyramine

Pregnancy & Lactation

Pregnancy
Contraindicated in pregnancy.
Lactation
Not recommended.

Price Intelligence

Rs 706.27
DRAP approved maximum price · per pack of 10 · approved 01 Jul, 2025
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 10Rs 706.27

Should you consider an alternative?

Other options containing Irbesartan, and what they are not.

Identical active ingredient at the same strength. Cheapest per unit first.

Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.